FOR CAMBRIDGE-BASED Biogen, it’s been the best of times and the worst of times. The biotech powerhouse saw its Alzheimer’s drug Aduhelm approved in June by the Food and Drug […]
Alzheimer’s disease
Posted inHealth Care
FDA’s controversial approval of Alzheimer’s drug draws calls for reform
WHEN MASS GENERAL BRIGHAM announced two weeks ago that it would not offer a controversial new drug treatment for Alzheimer’s disease to patients, it was an important statement from the […]
Posted inHealth Care
Insurers put squeeze on Biogen Alzheimer’s drug
CALL IT THE first big shot across Biogen’s bow in what may become a multi-billion-dollar war in which the hopes of millions for a way to hold back the ravages […]
Posted inOpinion
Alzheimer’s a growing public health crisis
STATE SEN. BARBARA L’ITALIEN’s mother, Claire, lived with her and her family for 20 years near the end of her life. Claire helped raise Barbara’s four children, enabled Barbara to […]